COMPANY · NIPC 512001529

Francisco Silva Ribeiro Lda.

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

Portal BASE records €231,973.82 across 16 contracts.

Follow (RSS) · What is RSS?

Identification

Company nameFrancisco Silva Ribeiro Lda.
NIPC512001529

None of the registers we read (GLEIF, TED and contract documents) identifies this company; the name comes from Portal BASE contracts.

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2012 to 2024. The table below gives the same values.2012: €490.8420122016: €18,327.282017: €10,957.9020172018: €175.802019: €75,011.0120192020: €67,994.692021: €16,005.5020212022: €16,889.882023: €21,763.1220232024: €4,357.80€75,011.01
Contracted value by year
YearContractsContract value
20122€490.84
20161€18,327.28
20172€10,957.90
20181€175.80
20191€75,011.01
20203€67,994.69
20211€16,005.50
20221€16,889.88
20232€21,763.12
20242€4,357.80
Contracted value by buyer
NameContractsContract value
Unidade de Saúde da Ilha do Faial8€99,949.18
Hospital da Horta, EPE2€93,472.08
Hospital da Horta, E. P. E. R.2€33,703.92
Unidade de Saúde da Ilha do Faial2€4,357.80
Unidade de Saúde da Ilha do Pico2€490.84
Contracted value by place of performance
NameContractsContract value
Horta14€231,482.98
Lajes do Pico2€490.84
Largest contracts
SubjectYearContract value
O presente procedimento tem por objeto o fornecimento de produtos farmacêuticos exclusivos, ao Hospital da Horta, E.P.E.R.2019€75,011.01
O presente procedimento tem por objeto a aquisição de produtos farmacêuticos para consumo hospitalar em 2020, ao Hospital da Horta, E.P.E.R.2020€33,528.12
O presente procedimento tem por objeto a aquisição de produtos farmacêuticos para consumo hospitalar em 2020, ao Hospital da Horta, E.P.E.R.2020€18,461.07
Aquisição Vacina pneumocócica - Pn 132016€18,327.28
Aquisição Vacinas PRV 20222022€16,889.88

Who they competed with

In 4 contracts with a list of competitors, the company took part and was awarded 4 (100%).

Companies with the most procedures in common
CompanyProcedures in common
MERCK SHARP DOHME3
Eduardo Caetano de Sousa3
Profarin2
Medifarma - José Horácio Rego Sousa Lda.2
Luís Peixoto2
BRISTOL MYERS SQUIBB FARMACEUTICA PORTUGUESA,S A1
http://www.chualgarve.min-saude.pt1
JANSSEN CILAG FARMACEUTICA LDA1
Unilfarma1
Quilaban1
MERCK1
NOVO NORDISK COMERCIO PRODUTOS FARMACEUTICOS1
ASTELLAS FARMA LDA1
IPSEN PORTUGAL PRODUTOS FARMACEUTICOS SA1
TAKEDA-FARMACEUTICOS PORTUGAL, LDA1
Astrazeneca1
CSL BEHRING1
BAXTER MEDICO FARMACEUTICA LDA1
ALLOGA LOGIFARMA, S.A.1
BIOGEN PORTUGAL, SOC FARMACÊUTICA, UNIPESSOAL1
PHARMAKERN PORTUGAL1
CELGENE - SOCIEDADE UNIPESSOAL LDA1
Accord Healthcare, Unipessoal, Lda1
ABBVIE, LDA1
N. O. Frayão Lda.1
Farmaçor - Comércio Prod. Quimicos Farmacêuticos Açores S.A.1
Açormédica1
BDRPHARMA, LDA.1
BAUSCH E LOMB, SA1

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

Links read in contract documents33 companies and 34 links. The list below gives the same content as text.BRISTOL MYERS … (NIPC 500048193)BRISTOL MYERS …NIPC 500134960 (NIPC 500134960)NIPC 500134960NIPC 500139962 (NIPC 500139962)NIPC 500139962http://www.chu… (NIPC 500162166)http://www.chu…JANSSEN CILAG … (NIPC 500189412)JANSSEN CILAG …MERCK SHARP DO… (NIPC 500191360)MERCK SHARP DO…Profarin (NIPC 500223238)ProfarinUnilfarma (NIPC 500293023)UnilfarmaQuilaban (NIPC 500399670)QuilabanMERCK (NIPC 500650870)MERCKNIPC 512001529 (NIPC 512001529)NIPC 512001529+22 in the list below

Dotted: competed in the same procedure. Dotted: same procedure.

22 more links

Investigations that mention it

No published investigation mentions this company by NIPC.